These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37251903)

  • 1. Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors.
    Albitar M; Zhang H; Charifa A; Ip A; Ma W; McCloskey J; Donato M; Siegel D; Waintraub S; Gutierrez M; Pecora A; Goy A
    Heliyon; 2023 May; 9(5):e16261. PubMed ID: 37251903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly sensitive fusion detection using plasma cell-free RNA in non-small-cell lung cancers.
    Hasegawa N; Kohsaka S; Kurokawa K; Shinno Y; Takeda Nakamura I; Ueno T; Kojima S; Kawazu M; Suehara Y; Ishijima M; Goto Y; Kojima Y; Yonemori K; Hayashi T; Saito T; Shukuya T; Takahashi F; Takahashi K; Mano H
    Cancer Sci; 2021 Oct; 112(10):4393-4403. PubMed ID: 34310819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital PCR-based evaluation of nucleic acid extraction kit performance for the co-purification of cell-free DNA and RNA.
    Deleu J; Schoofs K; Decock A; Verniers K; Roelandt S; Denolf A; Verreth J; De Wilde B; Van Maerken T; De Preter K; Vandesompele J
    Hum Genomics; 2022 Dec; 16(1):73. PubMed ID: 36587211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer.
    Fettke H; Kwan EM; Docanto MM; Bukczynska P; Ng N; Graham LK; Mahon K; Hauser C; Tan W; Wang XH; Zhao Z; Zheng T; Zhou K; Du P; Yu J; Huang Y; Jia S; Kohli M; Horvath LG; Azad AA
    Eur Urol; 2020 Aug; 78(2):173-180. PubMed ID: 32487321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol.
    Sorber L; Zwaenepoel K; Jacobs J; De Winne K; Goethals S; Reclusa P; Van Casteren K; Augustus E; Lardon F; Roeyen G; Peeters M; Van Meerbeeck J; Rolfo C; Pauwels P
    Cancers (Basel); 2019 Mar; 11(4):. PubMed ID: 30935089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and Therapeutic Potential of Circulating-Free DNA and Cell-Free RNA in Cancer Management.
    Hassan S; Shehzad A; Khan SA; Miran W; Khan S; Lee YS
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype.
    Albrecht LJ; Höwner A; Griewank K; Lueong SS; von Neuhoff N; Horn PA; Sucker A; Paschen A; Livingstone E; Ugurel S; Zimmer L; Horn S; Siveke JT; Schadendorf D; Váraljai R; Roesch A
    Clin Transl Med; 2022 Nov; 12(11):e1090. PubMed ID: 36320118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proof of concept: Detection of cell free RNA from EDTA plasma in patients with lung cancer and non-cancer patients.
    Mullins KE; Seneviratne C; Shetty AC; Jiang F; Christenson R; Stass S
    Clin Biochem; 2023 Aug; 118():110583. PubMed ID: 37182637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of Cell-Free DNA and Targeted NGS in Predicting Chromosomal Abnormalities of Patients With Myeloid Neoplasms.
    Ip A; Della Pia A; Kim GYG; Lofters J; Behrmann J; Patel D; Kats S; Estella JJ; De Dios I; Ma W; Pecora AL; Goy AH; Koprivnikar J; McCloskey JK; Albitar M
    Front Oncol; 2022; 12():923809. PubMed ID: 35774119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free DNA and RNA-measurement and applications in clinical diagnostics with focus on metabolic disorders.
    Drag MH; Kilpeläinen TO
    Physiol Genomics; 2021 Jan; 53(1):33-46. PubMed ID: 33346689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid Biopsy Based on Cell-Free DNA and RNA.
    Loy C; Ahmann L; De Vlaminck I; Gu W
    Annu Rev Biomed Eng; 2024 Jul; 26(1):169-195. PubMed ID: 38346275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diurnal stability of cell-free DNA and cell-free RNA in human plasma samples.
    Wagner JT; Kim HJ; Johnson-Camacho KC; Kelley T; Newell LF; Spellman PT; Ngo TTM
    Sci Rep; 2020 Oct; 10(1):16456. PubMed ID: 33020547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using cfRNA as a tool to evaluate clinical treatment outcomes in patients with metastatic lung cancers and other tumors.
    Raez LE; Danenberg K; Sumarriva D; Usher J; Sands J; Castrellon A; Ferraro P; Milillo A; Huang E; Soon-Shiong P; Reddy S; Danenberg P
    Cancer Drug Resist; 2021; 4(4):1061-1071. PubMed ID: 35582387
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-Free RNA Sequencing from Biofluid Samples.
    Zhang L; Liu X; Wang C; Li X; Tian G; Wang W
    Methods Mol Biol; 2023; 2695():9-25. PubMed ID: 37450109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
    Ray SK; Mukherjee S
    Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of liquid biopsy-based mutations in colorectal cancer by targeted sequencing assays.
    Szász I; Kiss T; Mokánszki A; Koroknai V; Deák J; Patel V; Jámbor K; Ádány R; Balázs M
    Mol Cell Probes; 2023 Feb; 67():101888. PubMed ID: 36513244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non-small cell lung cancer.
    Metzenmacher M; Hegedüs B; Forster J; Schramm A; Horn PA; Klein CA; Bielefeld N; Ploenes T; Aigner C; Siveke JT; Schuler M; Lueong SS
    Thorac Cancer; 2022 Aug; 13(15):2180-2191. PubMed ID: 35708207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Impact of Clonal Hematopoiesis on the Determination of RAS Mutations by Cell-Free DNA Testing in Routine Clinical Diagnostics.
    Roma C; Sacco A; Forgione L; Esposito Abate R; Lambiase M; Dotolo S; Maiello MR; Frezzetti D; Nasti G; Morabito A; De Luca A; Normanno N
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free Nucleic Acid as Promising Diagnostic Biomarkers for Gastric Cancer: a Systematic Review.
    Zhang Q; Du Z; Wang X; Li F; Liu Y; Sun J; Zhang L; Xiao Y; Lu X; Yu H; Liu T
    J Cancer; 2024; 15(10):2900-2912. PubMed ID: 38706900
    [No Abstract]   [Full Text] [Related]  

  • 20. Current challenges and best practices for cell-free long RNA biomarker discovery.
    Cabús L; Lagarde J; Curado J; Lizano E; Pérez-Boza J
    Biomark Res; 2022 Aug; 10(1):62. PubMed ID: 35978416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.